https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk scored a huge legal victory that … Read more
As counterfeit Ozempic circulates in the U.S., the Food and Drug Administration has issued a warning to Americans. In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg” were in the U.S. drug … Read more
Wegovy, eat your heart out. In a new research paper, scientists say they’ve discovered a naturally occurring hormone that might help people lose weight while avoiding the side effects commonly associated with semaglutide (the active ingredient in Ozempic and Wegovy) and similar drugs. A team of researchers at Stanford Medicine conducted the study, published last … Read more
Hacks star Megan Stalter had a hilarious response to people who “lie” about using Ozempic. “Let’s just say the trips to the bathroom would say otherwise, okay?” Stalter, 34, said on a Wednesday, March 13, episode of the “Grindr Presents: Who’s The A—–? with Katya” podcast. “We know if you’re on it because you’re s—ing … Read more
The US Food and Drug Administration has determined that semaglutide is no longer in shortage, a move that will have implications for patients taking cheaper, compounded versions of the drug. Semaglutide, the active ingredient in Novo Nordisk’s blockbuster diabetes and weight-loss medications Ozempic and Wegovy, has been on the FDA’s shortage list since March 2022. … Read more
Novo Nordisk’s semaglutide weight-loss (Wegovy) and diabetes (Ozempic) drugs are no longer in short supply, U.S. regulators said Feb. 21, 2025, a decision that’s expected to curtail widespread access to cheaper copies of the popular medications. Steve Christo/Corbis/Getty Images
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the Food and Drug Administration said on Friday. The FDA’s decision will threaten the … Read more
Steve Christo | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk‘s blockbuster diabetes drug Ozempic may also help people drink less alcohol. That’s according to new government-funded research … Read more
Cyndi Lauper has a fairly strict pre-tour diet — but that doesn’t mean the singer is willing to do (or take) anything to lose weight. “You see how thin everybody is now and the clothes aren’t made for big girls,” Lauper said in an interview with The Sunday Times published on Sunday, February 2. “I … Read more
The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular injection in the U.S. The drug is already widely used and covered to treat Type 2 diabetes. The FDA’s decision means Ozempic can now … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4